MIPH Income Statement - TTM - MINAPHARM Pharmaceuticals

Income Statement (TTM)

MINAPHARM Pharmaceuticals Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2021 12-31	2022 03-31	2022 06-30	2022 09-30	2022 12-31	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31
Revenue	2,200	2,361	2,583	2,754	2,918	3,005	3,032	3,212	3,442	3,621	3,794	4,003	4,025	3,892	3,904	3,916	4,423	5,665	6,288
Change (%)		7.33	9.39	6.64	5.96	2.99	0.88	5.93	7.16	5.20	4.78	5.53	0.54	-3.30	0.31	0.31	12.94	28.08	10.99
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	1,372	1,457	1,605	1,642	1,761	1,820	1,833	1,994	2,068	2,124	2,311	2,403	2,498	2,640	2,733	2,910	3,187	3,728	3,994
Change (%)		6.17	10.18	2.30	7.29	3.33	0.73	8.80	3.68	2.72	8.79	3.97	3.97	5.70	3.51	6.45	9.53	16.99	7.13
% of Revenue	62.37	61.69	62.14	59.61	60.36	60.56	60.47	62.10	60.08	58.67	60.92	60.02	62.07	67.84	70.01	74.30	72.05	65.81	63.52

Gross Operating Profit	828	904	978	1,112	1,157	1,185	1,199	1,217	1,374	1,496	1,483	1,601	1,527	1,252	1,171	1,007	1,236	1,937	2,294
Change (%)		9.27	8.11	13.76	3.99	2.47	1.12	1.56	12.86	8.92	-0.92	7.97	-4.62	-18.02	-6.44	-14.04	22.80	56.68	18.44
% of Revenue	37.63	38.31	37.86	40.39	39.64	39.44	39.53	37.90	39.92	41.33	39.08	39.98	37.93	32.16	29.99	25.70	27.95	34.19	36.48

SG&A	327	327	337	357	377	386	401	429	456	472	525	603	653	726	740	701	737	872	986
Change (%)		-0.10	3.28	5.84	5.52	2.34	4.09	7.00	6.26	3.50	11.07	15.00	8.18	11.19	1.93	-5.18	5.15	18.19	13.13
% of Revenue	14.86	13.83	13.06	12.96	12.91	12.83	13.24	13.37	13.26	13.04	13.83	15.07	16.21	18.64	18.94	17.91	16.67	15.38	15.68

R&D	40	39	43	46	53	46	47	46	46	59	76	98	127	151	154	156	149	131	142
Change (%)		-1.23	10.39	7.69	13.27	-12.89	1.81	-1.63	0.05	29.20	28.38	28.77	29.86	18.72	1.62	1.65	-4.41	-12.12	8.53
% of Revenue	1.80	1.66	1.67	1.69	1.80	1.53	1.54	1.43	1.33	1.64	2.01	2.45	3.17	3.89	3.94	3.99	3.38	2.32	2.27

OpEx	1,738	1,822	1,985	2,045	2,191	2,251	2,281	2,470	2,570	2,656	2,912	3,104	3,278	3,517	3,615	3,756	4,062	4,731	5,122
Change (%)		4.82	8.95	3.02	7.11	2.77	1.33	8.27	4.06	3.34	9.64	6.61	5.61	7.30	2.78	3.89	8.16	16.46	8.26
% of Revenue	79.03	77.18	76.87	74.26	75.07	74.91	75.24	76.90	74.68	73.35	76.75	77.54	81.45	90.37	92.60	95.91	91.85	83.51	81.45

Operating Income	461	539	597	709	727	754	751	742	872	965	882	899	747	375	289	160	361	934	1,166
Change (%)		16.80	10.88	18.66	2.62	3.64	-0.44	-1.16	17.46	10.69	-8.60	1.98	-16.97	-49.82	-22.90	-44.53	124.98	159.04	24.87
% of Revenue	20.97	22.82	23.13	25.74	24.93	25.09	24.76	23.10	25.32	26.65	23.25	22.46	18.55	9.63	7.40	4.09	8.15	16.49	18.55

Interest Expense	-75	-69	-62	-60	-53	-49	-46	-44	-50	-62	-90	-139	-194	-254	-316	-416	-503	-594	-695
Change (%)		-7.81	-10.66	-3.45	-11.05	-8.14	-5.04	-5.31	14.97	23.14	44.75	54.45	39.84	30.91	24.10	31.87	20.76	18.06	17.04
% of Revenue	-3.42	-2.93	-2.40	-2.17	-1.82	-1.63	-1.53	-1.37	-1.47	-1.72	-2.37	-3.47	-4.83	-6.54	-8.09	-10.63	-11.37	-10.48	-11.05

Net Income	271	301	345	428	452	466	477	481	563	613	548	486	307	-32	-137	-345	-252	157	194
Change (%)		10.87	14.84	23.81	5.70	3.18	2.28	0.80	17.05	8.85	-10.62	-11.34	-36.78	-110.42	327.55	152.30	-26.99	-162.34	23.80
% of Revenue	12.33	12.74	13.37	15.53	15.49	15.52	15.73	14.97	16.35	16.92	14.43	12.13	7.63	-0.82	-3.50	-8.81	-5.70	2.77	3.09

Source: Capital IQ

MINAPHARM Pharmaceuticals - Income Statement (TTM)

Income Statement (TTM)